This Section will be Updated Soon...!

1. Pharmocogenomic Study of Psychotropic Medication
2. Development of Biological Marker of Alzheimer’s Disease
3. Brain Imaging of Human Behavior and Psychiatric Illness

João Rodrigo Mesquita is an Adjunct Professor at the Polytechnic Institute of Viseu - Agrarian Superior School, and a researcher at the Research Center for Biodiversity and Genetic Resources, at the University of Porto, where he earned his PhD in 2012. He has been devoting efforts in epidemiology and biostatistics on surveys and surveillance schemes.

Epidemiology and biostatistics on surveys and surveillance schemes.

Mansher Singh is a research scientist in the Department of Surgery at Brigham & Women’s Hospital, Harvard Medical School. He has previous post-Doctoral experience at Yale University School of Medicine and has more than 35 peer-reviewed publications. He is currently a peer-reviewer of over 10 scientific journals. He has been extensively involved with preparation of multiple research grants and has received grants and multiple awards in the past. He is currently a per-reviewer of over 10 scientific journals.

Clinical Research

Sahba Mobini completed her B.Sci. in Materials Science and Engineering at Tabriz University and her M.Sci. in Biomaterials Engineering at Iran University of Science and Technology in 2004 and 2007, respectively. She earned her Ph.D. in Biomedical Engineering, specializing in biomaterials for tissue engineering and regenerative medicine at AmirKabir University of Technology, Tehran, Iran in June 2012. She was awarded a DAAD scholarship to visit research at MBZ, Dresden, Germany. In 2012, she began a postdoctoral research fellowship in the Avicenna Research Institute, Tehran, Iran gaining proficiency in stem cell technologies. She returned to Germany in 2014 to work on a research project funded by the AO Foundation at the Frankfurt Initiative for Regenerative Medicine at Goethe Universität. In June 2015, she relocated to the UK to undertake a postdoctoral research associated position at the University of Manchester in Prof. Sarah Cartmell’s group as part of a project funded by BBSRC.

Dr. Sahba Mobini’s background is in Materials Science and Engineering. Sahba’s research interests and activities over the past seven years have mainly centered on Biomaterials in Tissue Engineering. Specifically her research focused on natural polymers, ceramics and composites - in particular natural silk polymer- as scaffolding materials for bone and cartilage tissue engineering. She had experiences with natural scaffolds - decellularized tissues - such as human amniotic membrane as a substitute for skin tissue applications. Since 2014, she has focused on understanding the effect of electrical stimulation in regenerative medicine. She is studying, particularly combination of electrical stimulation and tissue engineering approaches in vitro, in vivo with clinical perspectives.

Sun-Hee Leem, Ph.D. Professor, Principal Investigator of Functional Genomics Laboratory Dept. of Biological Science; Dong-A University, Korea : [Address: 840 Hadan-Dong, Saha-Gu, Busan 604-714, Korea; Phone: +82-51-200-7268, Fax: +82-51-200-7269] I have been a faculty member since the year of 2000 at the Dept of Biology, Dong-A University in Busan, Korea, currently as a Professor. I received the Ph.D. degrees in Biology and postdoctoral training from the Osaka University in Japan. Also, I did postdoctoral training from NCI/NIH at Maryland, USA.
Research field: Cancer genomics; study of the genetic predispositions and molecular prognosis markers: Based on the microarray gene expression information of various cancers (bladder, liver, prostate, breast cancer etc.), discovering the key biomarkers related to prognosis, recurrence and progression. Validation through functional genomics of a key marker associated with the invasion and recurrence of a cancer. I also studied Characterization of minisatellites in cancer-related genes influencing susceptibility of specific carcinoma and development of nucleotide biomarker for diagnostic kit.

Cancer genomics; study of the genetic predispositions and molecular prognosis markers: Based on the microarray gene expression information of various cancers (bladder, liver, prostate, breast cancer etc.), discovering the key biomarkers related to prognosis, recurrence and progression. Validation through functional genomics of a key marker associated with the invasion and recurrence of a cancer. I also studied Characterization of minisatellites in cancer-related genes influencing susceptibility of specific carcinoma and development of nucleotide biomarker for diagnostic kit.

Dr. Yu Sun is a professor in Chinese Academy of Sciences. Upon completion of his PhD studies in Dalhousie University, Dr. Sun received postdoctoral training at University of British Columbia and Fred Hutchinson Cancer Research Center, respectively. In 2012, he obtained funding from the US DoD PCRP Idea Development, and started to work as an independent investigator at VA Seattle Medical Center and University of Washington. In 2014, Dr. Sun was supported by the National 1000 Elites Research Program of China and Established a laboratory at Chinese Academy of Sciences, Shanghai. Dr. Sun focuses on research of intracellular signaling network modulated by the DNA Damage Secretory Program (DDSP) upon treatment of solid tumors, as well as the pathological consequence of a damaged tumor microenvironment towards disease progression. His lab pursues rational design, preclinical development and clinical translation of novel chemotherapeutic agents to improve outcomes of chemotherapy, radiation and targeted therapy.

Dr. Sun focuses on research of intracellular signaling network modulated by the DNA Damage Secretory Program (DDSP) upon treatment of solid tumors, as well as the pathological consequence of a damaged tumor microenvironment towards disease progression. His lab pursues rational design, preclinical development and clinical translation of novel chemotherapeutic agents to improve outcomes of chemotherapy, radiation and targeted therapy.

Dr. Yulin Li is an Associate Professor in Engineering Research Centre for Biomedical Materials of Ministry of Education at East China University of Science and Technology, Shanghai, People's Republic of China and he is also a visiting researcher at CQM, University of Madeira, Portugal. He obtained his Ph.D. degree in Polymer Chemistry and Physics in 2005 from Chinese Academy of Sciences, People's Republic of China. Dr. Li started his first postdoctoral work on the topic of "Study of deformation mechanisms of polymer films via In Situ Atomic Force Microscopy" at Lille University of Science and Technology, France. In 2006, he moved to Biomaterials Centre, National Institute for Materials Science, Japan, and then to Department of Applied Chemistry, Kyushu University, Japan, as a postdoctoral researcher. He was appointed as an Assistant Researcher at Madeira Material and Chemistry Centre (CQM), University of Madeira, Portugal (2009 - 2014), under the scope of the program Science 2008 launched by FCT (Fundaçãopara a Ciência e a Tecnologia/Portuguese Science Foundation).

Dr. Li research interests are involved in the exploration of continuous-fiber-reinforced resin materials for engineering applications, and development of biomimetic materials for bone regeneration and oncology.

Dr. Hsiu-Chuan Chou is currently working as an Associate Professor at National Hsinchu University of Education in Taiwan since 2013. Dr. Chou received her PhD degree from King’s College, University of London in 2005. After 2 year post-doctoral training in the Cell Motility and Cytoskeleton research section in the Randall Division, she took a Researcher offer at Biomedical Laboratories in Industrial Technology Research Institute of Taiwan to develop therapeutic stem cells and diagnostic MRI nanoparticles for 3 years. Later on, Dr. Chou is moving into academic research labs with strong collaborative ties to biotech companies and hospitals. Dr. Chou’s group focuses on: immune cell migration, podosomes dynamics, MRI nanoparticle validation as well as proteomic approaches for the phenotypic hallmark traits and cellular signaling pathways in targeting toxic effect and drug resistance of cancer treatment.

Immune cell migration, Podosomes dynamics, MRI nanoparticle validation as well as proteomic approaches for the phenotypic hallmark traits and cellular signaling pathways in targeting toxic effect and drug resistance of cancer treatment.

Renke Zhou, Ph.D., is the Senior Biostatistician for Cancer Prevention and Population Sciences in the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine. She received a master’s of science in biology and a master’s of science in statistics from Texas Tech University in Lubbock and Ph.D. in biostatistics from The University of Texas School of Public Health in Houston. Her research focus is in genetic and molecular epidemiology, and she is at the forefront of developing innovative statistical methods to assess the roles of heredity and genetic susceptibility in the etiology of cancer, primarily brain and breast cancer. She is the member of the Brain Tumor Epidemiology Consortium (BTEC) and the Glioma International Case-control Consortium (GICC).

Her research focus is in genetic and molecular epidemiology, and she is at the forefront of developing innovative statistical methods to assess the roles of heredity and genetic susceptibility in the etiology of cancer, primarily brain and breast cancer.

Anita Peoples, PhD, is a Research Assistant Professor at the University of Rochester Medical Center. She received her PhD from the University of Rochester in the multidisciplinary field of Biophysics with a research focus in basic radiation science involving radiation-induced DNA damage leading to cancer. After the completion of her PhD, Dr. Peoples did her fellowship in the field of clinical cancer control science to be able to effectively conduct clinical research by combining both basic and clinical skill sets. Her research interest lies in clinical research in the early identification and prediction of cancer and its treatment related toxicities as well as in understanding these toxicities and the intricacies of conducting research in the clinical environment. In particular, Dr. Peoples research focuses on characterizing and developing biomarker for identifying and predicting thoracic radiation therapy-induced lung toxicities; examining behavioral interventions for the management and amelioration of radiotherapy - and chemotherapy - induced symptoms of dyspnea, insomnia, nausea, vomiting, cognitive impairment, and fatigue in cancer patients and survivors as well as predictors of these symptoms and the relationships that may exist between them.

Her research interest lies in clinical research in the early identification and prediction of cancer and its treatment related toxicities as well as in understanding these toxicities and the intricacies of conducting research in the clinical environment. In particular, Dr. Peoples research focuses on characterizing and developing biomarker for identifying and predicting thoracic radiation therapy-induced lung toxicities; examining behavioral interventions for the management and amelioration of radiotherapy - and chemotherapy - induced symptoms of dyspnea, insomnia, nausea, vomiting, cognitive impairment, and fatigue in cancer patients and survivors as well as predictors of these symptoms and the relationships that may exist between them.

I am Dr. Azam Bolhassani, an associate professor at Hepatitis and AIDS department in Pasteur Institute of Iran, working on vaccine design against HPV, HIV, and HCV infections. Different vaccines include DNA, Protein, Peptide and live vaccines. We are studying the use of different adjuvants and delivery systems for improving vaccine potency.

Vaccine design against HPV, HIV, and HCV infections. Different vaccines include DNA, Protein, Peptide and live vaccines. We are studying the use of different adjuvants and delivery systems for improving vaccine potency.

Christiane Pavani is a Professor at UniversidadeNove de Julho, in the master and PhD program of Biophotonics Applied to Heath Sciences. She graduated in Chemistry at São Paulo University (2003), followed by PhD in Sciences ate the same University (2009), working directly in Photodynamic Therapy (from synthesis to cell culture experiments) and continued in this area during Post-Docs. Ms. Pavani has published 14 technical publications in photobiology and has received fellowships from Brazillian Public Foundations (FAPESP and CNPq). Pavani’sresearch interests includephotoinduced biological effects, Laser/LED therapies and Photodynamic Therapy, from chemical bases, photochemical mechanisms, photobiological effects and clinical outcomes.

My research interests include photoinduced biological effects, Laser/LED therapies and Photodynamic Therapy, from chemical bases, photochemical mechanisms, photobiological effects and clinical outcomes.

I am assistant professor of endocrinology at Carol Davila University of Medicine and Pharmacy and consultant in endocrinology at the National Institute of Endocrinology in Bucharest, Romania. During my fifteen years career in endocrinology I have worked in the Pituitary and Neuroendocrine Diseases Department of the Institute and naturally developed a strong interest for neuroendocrinology. I have been awarded two grants (Erasmus and Society for Endocrinology) which enabled me to visit and work with the team of the Oxford Center of Diabetes, Endocrinology and Metabolism of Oxford University. This set the basis of a fruitful collaboration in the field of pituitary diseases. In the last years, besides this ongoing interest, I started working in the area of vitamin D deficiency. I currently live in Bucharest- my home town, together with my husband and two children. I am always very enthusiastic about meeting new colleagues, broadening my research views and getting new interdisciplinary perspectives.

Neuroendocrinology
Reproductive medicine
Vitamin D
Adrenal diseases
Oncogenesis
Quality of life

Prof. Daniela Puzzo (born November 14, 1973, Catania) is an Italian neuroscientist who contributed to study the role of amyloid-beta peptide in hippocampal synaptic plasticity and memory in physiological conditions and neurodegenerative disorders, such as Alzheimer’s disease. She graduated in Medicine and Surgery with honors and obtained her PhD in ”Applied Biomedical Sciences”and the specialization in Clinical Biochemistry at the University of Catania. She also earned a Music Piano Diploma and attended several masters in Integrative Medicine, focusing on herbal medicine and acupuncture. Prof. Puzzo performed her post-doctoral training at Nathan Kline Institute (Orangeburg, NY, USA) and at the Taub Institute for Research on Alzheimer’s disease and the Aging Brain at Columbia University (New York, NY, USA). She has been awarded for a fellowship at the Italian Academy for Advanced Studies in America and for the SIF Prize (Italian Society of Physiology). From 2008 she is Assistant Professor in Physiology at the University of Catania.

1. Role of amyloid-beta peptide in hippocampal synaptic plasticity and memory during aging and Alzheimer’s disease
2. Physiological role of amyloid-beta peptide in hippocampal synaptic plasticity and memory
3. Role of cyclic nucleotides in learning and memory
4. Phosphodiesterase inhibitors as a therapeutic target in aging and Alzheimer’s disease
5. Role of tau protein in Alzheimer’s disease

Joey Kwong is currently Associate Professor, Chinese Evidence-Based Medicine Centre and Executive Associate Director, Chinese Cochrane Center, based at the West China Hospital, Sichuan University, Chengdu, China. She is a registered pharmacist in the U.K. and received both her Master of Pharmacy and PhD in Medicinal Chemistry degrees from the University of Bath, U.K. Her previous roles include Managing Editor for Cochrane Heart Group, Cochrane Collaboration; Overseas Activities Coordinator for Hong Kong Branch of the Chinese Cochrane Centre; and Research Assistant Professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong. She has published over 40 articles in peer-reviewed journals and presented over 30 lectures on evidence-based medicine at international conferences and training workshops.

Her primary research interests are translational evidence-based medical research in the field of cardiovascular medicine and development of evidence-based clinical practice guidelines and health policies.

Oueslati Sabrine is a PHD DR at The Children's Hospital Bechir Hamza, Tunis,Tunisia. As a researcher, she's the author and the co-authors of several papers in peer-reviewed scientific journals. She has contributed to the organization and animation of many workshops and she has participated at several scientific meetings.
Her principal publications are: « Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in cystic fibrosis patients », accepted in Journal of Genetis, 2015;« Association of TGFB1 -509C/T polymorphism gene with clinical variability in cystic fibrosis patients: A case-control study»: in Pathologie Biologie Journal. 2015 Aug 13 doi: 10.1016/j.patbio.2015.07.003. «Preliminary study of haplotypes linked to the rare cystic fibrosis E1104X mutation in a Tunisian population» in Acta Physiol Hung. Journal 2015 Mar;102(1):86-93. «Etude des haplotypes associés à la mutation F508del dans une population Tunisienne», in Tunisian Journal RTBC ‘Revue Tunisienne de Biologie Clinique’, Vol 20, n° 1, 2013.

Genetics, Molecular Biology, Cell Biology, Clinical Research, Cystic Fibrosis disease, Biochemistry...

My name is Pier Vitale Nuzzo and I received in May 2015 the Medical Oncology degree from University of Genoa, after attending 5 years of fellowship at the Genoa University Hospital.
As you could easily assume from my CV, I mainly work in the genitourinary field and I am actively involved in the research projects of my Department. I am very interested in translational research.
At present, I am actively involved in a research project about prostate cancer, whose aim is to generate novel diagnostic and prognostic tools.
My group is particularly focused on the role of Periostin, an extracellular matrix protein, considered, on the basis of literature data, as a major putative player in human carcinogenesis.
I had the privilege to publish under the supervision of my tutor Prof. Boccardo interesting data on Periostin role in international scientific journals.
I recently applied for a post-doctoral (PhD) fellowship at Genoa University. I was just informed that I succeeded in being selected. The program officially starts on November 1th 2015 and lasts three years. What I can tell about that experience is that I surely enjoy international settings, where researchers and clinicians meet up creating a vibrant environment to share and discuss new ideas.

I mainly work in the genitourinary field and I am actively involved in the research projects of my Department. I am very interested in translational research.
At present, I am actively involved in a research project about prostate cancer, whose aim is to generate novel diagnostic and prognostic tools.
My group is particularly focused on the role of Periostin, an extracellular matrix protein, considered, on the basis of literature data, as a major putative player in human carcinogenesis.

Dr. Parker PhD MBBS MRCP is a physician specialising in diabetes and endocrinology and general internal medicine having received her undergraduate medical training at the University of Cambridge and Imperial College School of Medicine, United Kingdom. She undertook a Wellcome Trust Research Training Fellowship and PhD in Clinical Biochemistry at the University of Cambridge investigating mosaic overgrowth disorders caused by perturbations of the phosphoinositide 3-kinase-AKTsignalling. She has research interests in mosaic overgrowth, clinical trials and big data analysis, and working experience of next generation sequencing, bioinformatics, pre-clinical cellular studies, clinical trials of investigative medicinal products and non-interventional clinical trials, cellular and human phenotyping.

She has research interests in mosaic overgrowth, clinical trials and big data analysis, and working experience of next generation sequencing, bioinformatics, pre-clinical cellular studies, clinical trials of investigative medicinal products and non-interventional clinical trials, cellular and human phenotyping.